[Code of Federal Regulations]
[Title 40, Volume 21]
[Revised as of July 1, 2003]
From the U.S. Government Printing Office via GPO Access
[CITE: 40CFR166.20]

[Page 185-187]
 
                   TITLE 40--PROTECTION OF ENVIRONMENT
 
         CHAPTER I--ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)
 
PART 166--EXEMPTION OF FEDERAL AND STATE AGENCIES FOR USE OF PESTICIDES 
UNDER EMERGENCY CONDITIONS--Table of Contents
 
      Subpart B--Specific, Quarantine, and Public Health Exemptions
 
Sec. 166.20  Application for a specific, quarantine, or public health 
exemption.


    (a) General information required in an application for a specific, 
quarantine or public health exemption. An application must be submitted 
in writing by the head of the Federal or State agency, the Governor of 
the State involved, or their official designee. If a designee has been 
delegated authority to request exemptions, written authorization of such 
delegation must accompany the request or be on file with the Agency. In 
addition, the application must contain all applicable information 
specified in paragraphs (a) (1) through (11) of this section.
    (1) Identity of contact persons. (i) Unless otherwise specified, the 
person who submits the application will be considered the contact person 
for all matters relating to administration of the emergency exemption.
    (ii) Requests should identify by name and telephone number one or 
more qualified experts who may be contacted in case any questions arise 
concerning the application.
    (2) Description of the pesticide. The application shall contain a 
description of the pesticide(s) proposed for use under the exemption. 
Such information shall include:
    (i) For a federally registered pesticide product:
    (A) The registration number and the name of the pesticide product if 
a specific product is requested; or the formulation(s) requested if a 
specific product is not desired; and
    (B) A copy of any additional labeling proposed for the emergency 
exemption; or
    (ii) For any other pesticide products:
    (A) A confidential statement of formula or reference to one already 
submitted to the Agency; and
    (B) Complete labeling to be used in connection with the proposed 
exemption use.
    (3) Description of the proposed use. The application shall identify 
all of the following:
    (i) Sites to be treated, including their locations within the State;
    (ii) The method of application;
    (iii) The rate of application in terms of active ingredient and 
product;
    (iv) The total acreage or other appropriate unit proposed to be 
treated;
    (v) The total amount of pesticide proposed to be used in terms of 
both active ingredient and product; and
    (vi) All applicable restrictions and requirements concerning the 
proposed use and the qualifications of applicators using the pesticide.
    (4) Alternative methods of control. The application shall contain:
    (i) A detailed explanation of why the pesticide(s) currently 
registered for the particular use proposed in the application is not 
available in adequate supplies and/or effective to the degree needed to 
control the emergency. If the applicant states that an available 
registered pesticide is ineffective for the given situation, the 
statement must be

[[Page 186]]

supported by field data which demonstrate ineffectiveness of registered 
pesticides, or, if such data are unavailable, statements by qualified 
agricultural experts, extension personnel, university personnel or other 
persons similarly qualified in the field of pest control; and
    (ii) A detailed explanation of why alternative practices, if 
available, either would not provide adequate control or would not be 
economically or environmentally feasible.
    (5) Effectiveness of proposed use. The application shall contain 
data, a discussion of field trials, or other evidence which provide the 
basis for the conclusion that the proposed pesticide treatment will be 
effective in dealing with the emergency.
    (6) Discussion of residues for food uses. If the proposed use is 
expected to result in residues of the pesticide in or on food, the 
application shall list the food likely to contain such residues and 
shall contain an estimate of the maximum amount of the residue likely to 
result from the proposed use, together with the information on which 
such estimates are based.
    (7) Discussion of risk information. The application shall address 
the potential risks to human health, endangered or threatened species, 
beneficial organisms, and the environment expected to result from the 
proposed use, together with references to data and other supporting 
information.
    (8) Coordination with other affected State or Federal agencies. If 
the proposed use of the pesticide is likely to be of concern to other 
Federal or State agencies, the application shall indicate that such 
agencies have been contacted prior to submission of the application, and 
any comments received from such agencies shall be submitted to EPA.
    (9) Notification of registrant or basic manufacturer. The 
application shall contain a statement that the registrants of all 
pesticide products proposed for use or, if appropriate, the basic 
manufacturer have been notified that a request has been made to the 
Agency for use of the pesticide under a specific, quarantine, or public 
health exemption.
    (10) Description of proposed enforcement program. Prior to approval, 
the applicant shall provide an explanation of the authority of the 
applicant or related State or Federal agencies for ensuring that use of 
the pesticide under the proposed exemption would comply with any special 
requirements imposed by the Agency and a description of the program and 
procedures for assuring such compliance.
    (11) Repeated uses. Applications for the use of a pesticide at a 
site for which the applicant has previously been exempted under section 
18 shall contain an interim report summarizing the results of the 
specific, quarantine, or public health exemption previously issued, if 
the application is submitted prior to the time the final report for the 
previous exemption is due. The interim report shall contain that 
information specified in Sec. 166.32 to the extent available at the time 
the application is made.
    (b) Information required for a specific exemption. An application 
for a specific exemption shall provide all of the following information, 
as appropriate, concerning the nature of the emergency:
    (1) The scientific and common name of the pest or pest complex;
    (2) A discussion of the events which brought about the emergency 
condition;
    (3) A discussion of the anticipated risks to endangered or 
threatened species, beneficial organisms, or the environment that would 
be remedied by the proposed use of the pesticide; and
    (4) A discussion of the anticipated significant economic loss, 
together with data and other information supporting the discussion, 
which addresses all of the following:
    (i) Historical net and gross revenues for the site;
    (ii) The estimated net and gross revenues for the site without the 
use of the proposed pesticide; and
    (iii) The estimated net and gross revenues for the site with use of 
the proposed pesticide.
    (c) Information required for a quarantine exemption. An application 
for a quarantine exemption shall provide all of the following 
information concerning the nature of the emergency:
    (1) The scientific and common name of pest;

[[Page 187]]

    (2) The origin of pest and the means of its introduction or spread 
if known; and
    (3) The anticipated impact of not controlling the pest.
    (d) Information required for a public health exemption. An 
application for a public health exemption shall provide all the 
following information concerning the nature of the emergency:
    (1) The scientific and common name of the pest to be controlled and, 
if the pest is a vector, a description of the disease it is expected to 
transmit;
    (2) A discussion of the magnitude of the health problems which are 
expected to occur without the pesticide use; and
    (3) Discussion of the availability of medical treatment for the 
health problem.

[51 FR 1902, Jan. 15, 1986, as amended at 58 FR 34203, June 23, 1993]